PMID- 9459626 OWN - NLM STAT- MEDLINE DCOM- 19980317 LR - 20151119 IS - 1050-7256 (Print) IS - 1050-7256 (Linking) VI - 7 IP - 6 DP - 1997 Dec TI - CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. PG - 843-6 AB - Susceptibility to Graves' disease (GD) is determined by environmental and genetic factors. The genetic susceptibility to GD is conferred by genes in the human leukocyte antigen (HLA), and several other genes unlinked to HLA are thought to contribute to the development of GD. Three recent papers described the association of GD with the CTLA-4 gene. CTLA-4 is a candidate gene for T-cell mediated autoimmune diseases because it is a negative regulator of T-cell proliferation. As CTLA-4 association with GD may be influenced by the racial composition of the population, it is important to study it in other ethnic groups. We investigated the distribution of CTLA-4 gene polymorphism in 153 Japanese patients with GD (35 males and 118 females) and 200 controls (96 males and 104 females). An A/G transition at position 49 of exon 1 was analyzed by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The distribution of genotype frequencies differs between GD and controls (chi2 = 9.46, 2 degrees of freedom, p < 0.01). The presence of at least one G allele (GG or AG) conferred an odds ratio of 2.64 (95% CI = 1.92-3.36). The present study supported the association of the CTLA-4 gene with GD in Japanese and showed that the CTLA4 gene could be one of the non-HLA linked susceptibility genes for GD. FAU - Yanagawa, T AU - Yanagawa T AD - Department of Medicine, Nerima General Hospital, Tokyo, Japan. FAU - Taniyama, M AU - Taniyama M FAU - Enomoto, S AU - Enomoto S FAU - Gomi, K AU - Gomi K FAU - Maruyama, H AU - Maruyama H FAU - Ban, Y AU - Ban Y FAU - Saruta, T AU - Saruta T LA - eng PT - Journal Article PL - United States TA - Thyroid JT - Thyroid : official journal of the American Thyroid Association JID - 9104317 RN - 0 (Antigens, CD) RN - 0 (Antigens, Differentiation) RN - 0 (CTLA-4 Antigen) RN - 0 (CTLA4 protein, human) RN - 0 (Immunoconjugates) RN - 7D0YB67S97 (Abatacept) SB - IM MH - Abatacept MH - Antigens, CD MH - Antigens, Differentiation/*genetics MH - CTLA-4 Antigen MH - Data Interpretation, Statistical MH - Female MH - Gene Frequency MH - Genes/*genetics MH - Genetic Predisposition to Disease MH - Genotype MH - Graves Disease/epidemiology/*genetics MH - Humans MH - *Immunoconjugates MH - Japan/epidemiology MH - Male MH - Polymorphism, Genetic MH - Sex Factors EDAT- 1998/02/12 00:00 MHDA- 1998/02/12 00:01 CRDT- 1998/02/12 00:00 PHST- 1998/02/12 00:00 [pubmed] PHST- 1998/02/12 00:01 [medline] PHST- 1998/02/12 00:00 [entrez] AID - 10.1089/thy.1997.7.843 [doi] PST - ppublish SO - Thyroid. 1997 Dec;7(6):843-6. doi: 10.1089/thy.1997.7.843.